We are live on ! Find out more
BIM

BlackRock Investment Management Portfolio holdings

AUM $86.4B
1-Year Est. Return 28.54%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+28.54%
3 Year Est. Return
+50.87%
5 Year Est. Return
10 Year Est. Return
AUM
$67.4B
AUM Growth
+$6.82B
Cap. Flow
+$1.04B
Cap. Flow %
1.54%
Top 10 Hldgs %
13.22%
Holding
3,497
New
147
Increased
717
Reduced
2,443
Closed
97

Sector Composition

Rank Sector Weight
1 Financials 15.98%
2 Healthcare 11.93%
3 Industrials 11.4%
4 Technology 10.8%
5 Energy 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COVS
3201
DELISTED
Covisint Corporation
COVS
$214K ﹤0.01%
+17,078
New +$217K
VSB
3202
DELISTED
VANTAGESOUTH BANCHARES, INC
VSB
$212K ﹤0.01%
40,288
-197
-0.5% -$1.02K
FOLD
3203
DELISTED
Amicus Therapeutics
FOLD
$209K ﹤0.01%
88,750
+437
+0.5% +$959
LWAY icon
3204
Lifeway Foods
LWAY
$456M
$209K ﹤0.01%
13,052
-297
-2% -$4.38K
KIOR
3205
DELISTED
KIOR, INC CLASS A COM STK
KIOR
$206K ﹤0.01%
122,710
+415
+0.3% +$904
SWSH
3206
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
$203K ﹤0.01%
39,485
-94
-0.2% -$541
XBKS
3207
DELISTED
Xenith Bankshares, Inc. Common Stock
XBKS
$201K ﹤0.01%
11,457
+69
+0.6% +$1.05K
RGLS
3208
DELISTED
Regulus Therapeutics
RGLS
$200K ﹤0.01%
225
-4
-2% -$3.44K
PLMT
3209
DELISTED
PALMETTO BANCSHARES, INC. (SC) COMMON STOCK
PLMT
$197K ﹤0.01%
15,167
+329
+2% +$4.28K
ZU
3210
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
$196K ﹤0.01%
+4,736
New +$181K
ING icon
3211
ING
ING
$101B
$194K ﹤0.01%
13,827
-1,348
-9% -$17.2K
FBIO icon
3212
Fortress Biotech
FBIO
$87.4M
$193K ﹤0.01%
4,887
IEV icon
3213
iShares Europe ETF
IEV
$1.7B
$190K ﹤0.01%
4,003
+654
+20% +$29.8K
BIND
3214
DELISTED
BIND THERAPEUTICS INC
BIND
$190K ﹤0.01%
+12,559
New +$160K
TRAW icon
3215
Traws Pharma
TRAW
$8.22M
0
RSYS
3216
DELISTED
Radisys Corp
RSYS
$184K ﹤0.01%
80,322
-894
-1% -$2.38K
KRO icon
3217
KRONOS Worldwide
KRO
$985M
$183K ﹤0.01%
9,598
+51
+0.5% +$805
CIFC
3218
DELISTED
CIFC LLC Common Shares
CIFC
$183K ﹤0.01%
23,466
BXC icon
3219
BlueLinx
BXC
$717M
$182K ﹤0.01%
9,326
-637
-6% -$11.4K
FRF
3220
DELISTED
FORTEGRA FINL CORP COM STK (DE)
FRF
$181K ﹤0.01%
21,847
-530
-2% -$4.12K
STRP
3221
DELISTED
Straight Path Communications Inc.
STRP
$179K ﹤0.01%
21,857
-1,085
-5% -$7.11K
VMEM
3222
DELISTED
VIOLIN MEMORY, INC.
VMEM
$176K ﹤0.01%
+11,127
New +$240K
ESPR
3223
DELISTED
Esperion Therapeutics
ESPR
$171K ﹤0.01%
12,420
+756
+6% +$11K
VUG icon
3224
Vanguard Morningstar Growth ETF
VUG
$228B
$171K ﹤0.01%
+11,010
New +$163K
VIAS
3225
DELISTED
VIASYSTEMS GROUP INC COM STK (DE)
VIAS
$167K ﹤0.01%
12,181
-249
-2% -$3.6K

Similar funds

BlackRock Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, BlackRock Investment Management held 3,497 positions worth $67.4B, up 11% from $60.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

BlackRock Investment Management's Q4 2013 filing shows 147 new, 717 increased, 2,443 reduced and 97 closed positions. Its largest new stake was Liberty Global Class A: 4,210,324 shares worth $155M. The largest sale was Viacom Inc. Class B, an estimated $76.9M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • BlackRock Investment Management's largest Q4 2013 buy was Liberty Global Class A: 4,210,324 shares worth $155M.
  • BlackRock Investment Management added most to Meta Platforms (Facebook) in Q4 2013, an estimated $97.5M increase.
  • BlackRock Investment Management's biggest Q4 2013 reduction was Viacom Inc. Class B, cutting an estimated $76.9M.
  • BlackRock Investment Management fully exited DELL INC in Q4 2013, selling an estimated $31.3M.
  • BlackRock Investment Management's ten largest holdings make up 13% of its $67.4B portfolio in Q4 2013.
  • BlackRock Investment Management opened 147 new positions and closed 97 in Q4 2013.
  • BlackRock Investment Management's portfolio value rose 11% quarter-over-quarter to $67.4B.

Based on BlackRock Investment Management's 13F filing for Q4 2013, filed 12 Feb 2014.